SORL1 downregulation enhances the amyloidogenic process of APP and significantly increases the risk of sporadic Alzheimer′s disease (SAD) and familial Alzheimer′s disease (FAD) [83,84]. This evidence concerns the gene APP and familial Alzheimer disease.